UQ and Vaxxas win global prize to accelerate patch-based mRNA vaccine for COVID-19

The University of Queensland’s BASE facility – within the Australian Institute for Bioengineering and Nanotechnology (AIBN) – and Brisbane-based biotechnology company Vaxxas have been announced as stage winners of a prestigious global prize to accelerate a patch-based mRNA vaccine for COVID-19.

F. Hoffmann-La Roche in artificial intelligence: Theme innovation strategy

Share this article F. Hoffmann-La Roche grant share with artificial intelligence as a theme is 18% in Q3 2023. Grant share is based on the

March 5, 2024

NHS rolls out “more convenient” Ocrevus injection for multiple sclerosis – Pharmaceutical Technology

Roche’s Ocrevus is currently offered on the NHS via twice-yearly intravenous (IV) infusions. Image credit: Shutterstock / Tong_stocker. England’s National Health Service (NHS) has said

July 12, 2024

FDA hearing set to discuss advisory committee members’ conflicts and more – Pharmaceutical Technology

(From left to right) CBER director Dr Peter Marks and CDER director Dr Patrizia Cavazzoni at a virtual town hall at the BIO International Conference.

June 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.